Cel-Sci Corp (CVM) concluded trading on Thursday at a closing price of $0.42, with 9.28 million shares of worth about $3.9 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -63.22% during that period and on February 20, 2025 the price saw a loss of about -17.50%. Currently the company’s common shares owned by public are about 77.21M shares, out of which, 75.33M shares are available for trading.
Stock saw a price change of 1.78% in past 5 days and over the past one month there was a price change of 7.44%. Year-to-date (YTD), CVM shares are showing a performance of 5.78% which decreased to -81.92% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.33 but also hit the highest price of $2.50 during that period. The average intraday trading volume for Cel-Sci Corp shares is 1.07 million. The stock is currently trading 3.84% above its 20-day simple moving average (SMA20), while that difference is down -13.07% for SMA50 and it goes to -55.26% lower than SMA200.
Cel-Sci Corp (AMEX: CVM) currently have 77.21M outstanding shares and institutions hold larger chunk of about 8.94% of that.
The stock has a current market capitalization of $32.66M and its 3Y-monthly beta is at 0.66. It has posted earnings per share of -$0.47 in the same period. It has Quick Ratio of 0.91 while making debt-to-equity ratio of 0.98. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CVM, volatility over the week remained 23.58% while standing at 13.09% over the month.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on January 13, 2020 offering a Buy rating for the stock and assigned a target price of $18 to it. Coverage by Dawson James stated Cel-Sci Corp (CVM) stock as a Buy in their note to investors on March 02, 2015, suggesting a price target of $3 for the stock.
